C
Caris Life Sciences, Inc. Common Stock (CAI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$31.76
+1.51 (+4.97%)
Market Cap: $8.55B
Last updated: Oct 16, 2026 at 1:54 PM ET
Earnings
Performance (10Y)
Beat Rate
60%(3/5)Avg Surprise
-542.71%Upcoming Estimates
Period ending Sep 30, 2026
EPS Consensus$0.02
Range$-0.01 - $0.07
10 analysts
EPS Revisions
3
0
7d3
6
30dEPS Estimate DriftChange to current
90d ago$0.04-49.3%
60d ago$0.03-19.3%
30d ago$0.03-25.3%
7d ago$0.03-15.3%
Current$0.02
Revenue Consensus
$255MRange$243M - $263M
13 analysts
Period ending Dec 31, 2026
EPS Consensus$0.12
Range$0.02 - $0.25
11 analysts
Revenue Consensus
$327MRange$302M - $332M
14 analysts
Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$29.17
SMA 20$30.10
SMA 50$26.86
SMA 200$21.27
EMA 10$29.80
EMA 20$29.26
EMA 50$26.72
EMA 200$23.29
MACD
Line: 0.92Signal: 1.03Hist: -0.11
ADX
ADX: 37.2+DI: 34.0-DI: 12.0
Aroon & PSAR
Aroon Up36.0
Aroon DownN/A
PSAR$25.98
Bollinger Bands
Upper Band$33.36
Lower Band$26.84
%B Position2167%(Upper)
Band Width0.75
RSI (14-Day)
Neutral
62.7
Momentum Oscillators
Stoch %K68.2
Stoch %D59.7
Williams %R-12.0
ROC (10d)12.0%
Momentum3.41
CCI (20d)42.8
MFI (14d)45.8
Volatility Measures
ATR (14d)$1.92(6.1%)
StdDev (20d)1.63
Hist Vol66.8%(High)
Volume Flow
VWAP$30.90
OBV-18.5M
AD Line9.6M
CMF (20d)0.047
Volume Metrics
Avg Vol (20d)4.9M
Vol Ratio0.7x
VWMA (20d)$30.09
Pivot Points
R3$34.02
R2$32.78
R1$31.52
Pivot Point$30.27
S1$29.01
S2$27.76
S3$26.50
Advanced Oscillators
TSI14.56
Ultimate Osc67.6
KST119.54
Financial Data
Related GNG Research
No research available
Be the first to write about CAI
News
CAI Valuation and Fair Value
- P/E
- -174.7x
- Forward P/E
- 43.3x
- P/FCF
- 72.5x
- P/B
- 15.2x
CAI Profitability: Margins, ROIC and FCF
- Gross margin
- 69.7%
- Operating margin
- 10.2%
- Net margin
- 10.6%
- ROE
- 20.1%
- FCF margin
- 12.5%
- FCF yield
- 1.4%
CAI Competitors
Sector: Healthcare
CAI Analyst Ratings
- Consensus
- Buy
- Analysts
- 14
- Strong Buy
- 1
- Buy
- 9
- Hold
- 4
- Sell
- 0
- Strong Sell
- 0
CAI Bull Case vs Bear Case
Bull case
- CAI grew quarterly revenue 45.4% year over year.
- 71.4% of CAI's analyst ratings are Buy or Strong Buy.
CAI Earnings: Beat Rate and Next Report
- Beat rate
- 3 of 6 quarters (50.0%)
- Average surprise
- -542.7%
- EPS estimate (fiscal period ending Sep 30, 2026)
- $0.02
- Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
- 3 up, 6 down
Frequently Asked Questions About CAI
Does CAI pay dividends?
Caris Life Sciences, Inc. Common Stock (CAI) does not currently pay a regular dividend.
What is CAI's market cap?
Caris Life Sciences, Inc. Common Stock (CAI) has a market capitalization of $8.55B with a current stock price of $31.76.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.